Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer
Galsky M, Diefenbach M, Mohamed N, Baker C, Pokhriya S, Rogers J, Atreja A, Hu L, Tsao C, Sfakianos J, Mehrazin R, Waingankar N, Oh W, Mazumdar M, Ferket B. Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer. JCO Clinical Cancer Informatics 2017, 1: 1-12. PMID: 30657403, PMCID: PMC6874030, DOI: 10.1200/cci.17.00116.Peer-Reviewed Original ResearchConceptsMuscle-invasive bladder cancerEffect of neoadjuvant chemotherapyNeoadjuvant chemotherapyMuscle-invasive bladder cancer treated with cystectomyHazard ratioBladder cancerFacility-level variablesTreatment of muscle-invasive bladder cancerUS life tablesInternal-external cross-validationDeath riskAssociated with shorter survivalPilot usability testingAssociated with longer survivalBladder cancer-specificClinical T stageMedian overall survivalNeoadjuvant chemotherapy useWeb-based toolOther-cause mortalityAbsolute risk reductionHigh-volume facilitiesIndividualized survival estimatesOverall survivalT stage
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply